http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Canadian Securities Exchange Reports June 2026 Performance Figures
-
DBV Technologies Announces the Filing of its 2026 Half-Year Report ― Conditions for Accessing or Consulting the Report
-
Appian To Announce Second Quarter 2026 Financial Results on August 6, 2026
-
DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update
-
Guggenheim Securities Hires David Cannon to Strengthen Financial Sponsors Investment Banking Practice
-
Union Pacific Receives First Stick of Long Rail as Rocky Mountain Steel Mills Opens New Rail Mill
-
Q2 New-Vehicle Purchases with Negative Equity Trade-Ins Hit Record Monthly Payments and Interest Costs, Edmunds Reports
-
Blackbaud previews AI admissions tool for K-12 private schools
-
Blackbaud Unveils New AI Innovation for K-12 Independent Schools with Admissions Agent in Development
-
Palmetto Publishing Releases Eric R. Thomas's New Middle Grade Novel About Four Young Jazz Musicians
-
Palmetto Publishing Releases Eric R. Thomas's New Middle Grade Novel About Four Young Jazz Musicians
-
OUTKICK FINISHED Q4 2026 WITH STRONG GROWTH IN UNIQUE VISTORS, MINUTES, AND VIEWS
-
Riverbed Named a Leader in the 2026 IDC MarketScape for Worldwide Digital Employee Experience
-
Viper Networks Continues Strategic Rebranding Effort, Expands Services
-
Mike Jerich Named Flexera CEO as Company Enters New Stage of AI-Driven Growth
-
Electrified Materials closes $9.5M Series A preferred stock offering
-
American Resources' Electrified Materials Announces Closing of its Previously Announced Private Placement for Gross Proceeds of $9.5 Million
-
22nd Century Group names Katherine Rouse-Bailey as VP of Marketing
-
eClinicalWorks and healow Genie Help Hope Family Care Center Cut After-Hours Call Burden by 90% While Driving Significant Cost Savings
-
CalAmp Expands Remote Monitoring Support for Modbus-Enabled Specialty Equipment
-
22nd Century Group (Nasdaq: XXII) Appoints Katherine Rouse-Bailey as Vice President of Marketing
-
Belden Earns 2026 Great Place To Work Certification
-
Belden to Announce Second Quarter 2026 Results
-
Leading Technology Company Essence Group Embeds AI Across the Entire Organization, With R&D Leading the Way
-
MilliporeSigma Announces Opening of BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe
-
Koddi Expands Commerce Media Targeting Capabilities Through New GIPHY and LiveRamp Collaboration
-
Union Pacific Corporation Announces Second Quarter 2026 Earnings Release Date
-
Scholar Rock to Report Second Quarter 2026 Financial Results on August 6, 2026
-
Soluna names ex-Microsoft executive as chief development officer
-
EMA approves combining HLA patient groups in Greenwich LifeSciences trial
-
Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01
-
Pacific Ridge Announces Drilling Plans for the Kliyul and RDP Copper-Gold Projects
-
Soluna Appoints Microsoft Hyperscale Executive Ryan Carver to Lead Soluna’s AI
-
BlackSky to Host Second Quarter 2026 Results Conference Call
-
Abitibi Metals Continues to Strengthen Leadership Team with the Appointment of Ben Pullinger as Senior Vice President of Corporate Development and Growth
-
FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
-
Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
-
Trade Nation Wins 2026 Online Money Awards for Third Consecutive Year
-
NAMI/Ipsos Poll: Trust in 988 Continues to Grow, 7 in 10 Americans Would Contact the Lifeline in a Mental Health Crisis
-
Parallel Announces Partnership with Google Cloud for Agentic Web Search on Gemini Enterprise Agent Platform
-
Aelis Farma's Down syndrome trial clears safety review
-
Aelis Farma Receives a Positive Recommendation From the Independent Data Monitoring Committee to Continue the Phase 2b Study of AEF0217 in People With Down Syndrome Without Modification
-
Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma
-
BASEBALL'S GRADY EMERSON AND SOCCER'S MADDIE DIMARIA NAMED GATORADE BEST PLAYERS OF THE YEAR
-
Visionstate to Pause LIFE Offering and Re-Examine Financing Approach
-
Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy
-
Insomnia Cookies Served 10 Million Scoops Last Year--And Most People Still Don't Know It Makes Its Own Ice Cream
-
Eden Capital Announces Kate Jhaveri as New Operating Partner
-
Final Call: Dallas Summer Boat Show Cruises Into Dallas This Weekend Only
-
Primit Season 1 Officially Launches: $100,000 Avalanche On-Chain Perp Trading Incentive Event Now Live
